Onalespib (AT13387)
Catalog No. A11062
Onalespib (AT13387)是Hsp90的靶向抑制剂,可抑制其伴侣功能并促进涉及肿瘤细胞增殖和存活的致癌信号蛋白的降解。
- Boucherat O, .et al. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension, Am J Respir Crit Care Med, 2018, Jul 1;198(1):90-103 PMID: 29394093
- Olivier Boucherat, .et al. HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension, Sci Rep, 2017, 7: 4546 PMID: 28674407
- Hiroki Murano, .et al. A purine-type heat shock protein 90 inhibitor promotes the heat shock response in Arabidopsis, Plant Biotechnol Rep, 2017, 11:107-113
Catalog Num | A11062 |
---|---|
M. Wt | 409.5 |
Formula | C24H31N3O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 912999-49-6 |
Synonyms | AT-13387 |
SMILES | CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O |
Onalespib (AT13387)是Hsp90的靶向抑制剂,可抑制其伴侣功能并促进涉及肿瘤细胞增殖和存活的致癌信号蛋白的降解。
Targets
HSP90 (Cell-free assay) | ||||
18 nM |
In vitro (25°C) | DMSO | 22 mg/mL (53.72 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+30% PEG 300+ddH2O (prepare before use) | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.42 mL | 122.1 mL | 244.2 mL |
0.5 mM | 4.88 mL | 24.42 mL | 48.84 mL |
1 mM | 2.44 mL | 12.21 mL | 24.42 mL |
5 mM | 0.49 mL | 2.44 mL | 4.88 mL |
*The above data is based on the productmolecular weight 409.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.